Andrenocortical carcinomas: Twelve-year prospective experience (294 views)
World J Surg (ISSN: 0364-2313), 2004 Sep; 28(9): 896-903.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 1.952, 5-year impact factor: 2.79
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-6344264964&partnerID=40&md5=9b1766d87c182402cc1baa1e393aa632
Keywords: Androstenedione, Estradiol, Estriol, Hydroxyprogesterone, Prasterone Sulfate, Testosterone, Adrenal Cortex Carcinoma, Adult, Arterial Pressure, Article, Cancer Recurrence, Cancer Staging, Cancer Surgery, Cardiovascular Risk, Clinical Article, Clinical Feature, Disease Association, Disease Severity, Early Diagnosis, Endocrine Function, Female, Human, Hyperadrenocorticism, Hypertension, Metabolic Regulation, Patient Monitoring, Prediction, Prognosis, Prospective Study, Rare Disease, Risk Factor, Adrenal Cortex Neoplasms, Adrenocortical Carcinoma, Middle Aged, Prospective Studies, Time Factors, Treatment Outcome,
Affiliations:
*** IBB - CNR ***
Dept. of Molec./Clin. Endocrinol., Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
Dept. of Anat. Pathol. and Cytology, Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
Dept. of Biomorphol. and Funct. Sci., Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
Dept. of Molec. /Clin. Endocrinol., Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
References:
Hanna, N.H., Kenady, E., Advances in the management of adrenal tumours (2000) Curr. Opin. Oncol., 11, pp. 49-5
Thompson, N.W., Cheung, P.S.Y., Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas (1987) Surg. Clin. North Am., 67, pp. 423-436
Søreide, J.A., Brabrand, K., Thoresen, Sø., Adrenal cortical carcinoma in Norway, 1970-1984 (1992) World J. Surg., 16, pp. 663-668
McFarlane, D.A., Cancer of the adrenal cortex: The natural history, prognosis and treatment in a study of fifty-five cases (1958) Ann. R. Coll. Surg. Engl., 23, p. 155
Luton, J.P., Cerdas, S., Billaud, L., Clinical features of adrenocortical carinoma, prognostic factors, and the effects of mitotane therapy (1990) N. Engl. J. Med., 322, pp. 1195-1201
Henley, D.J., Van Heerden, J.A., Grant, C.S., Adrenal cortical carcinoma: A continuing challenge (1983) Surgery, 94, pp. 926-931
Decker, R.A., Kuehner, M.E., Adrenocortical carcinoma (1991) Am. Surg., 57, pp. 502-513
Icard, P., Goudet, P., Charpenay, C., Adrenocortical carcinomas: Surgical trends and results of a 253 patient series from the French Association of Endocrine Surgeons study group (2001) World J. Surg., 25, pp. 891-897
Vassilopoulou-Sellin, R., Schultz, P.N., Adrenocortical carcinoma. Clinical outcome at the end of the 20th century (2001) Cancer, 92, pp. 1113-1121
Mantero, F., Terzolo, M., Arnaldi, G., Survey on adrenal incidentaloma in Italy (2000) J. Clin. Endocrinol. Metab., 85, pp. 637-644
Zarrilli, L., Marzano, L.A., Tauchmanovà, L., Incidentalomi surrenalici: Risultato di uno studio prospettico di 100 casi. Focus - La chirurgia dei surreni oggi. Ospedali d'Italia (1999) Chirurgia (Bucur), 5, pp. 655-659
Wajchenberg, B.L., Albergaria-Pereira, M.A., Adrenocortical carcinoma: Clinical and laboratory observation (2000) Cancer, 88, pp. 711-736
Bertagna, Ch., Orth, D.N., Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Review (1981) Am. J. Med., 71, pp. 855-875
Chrousos, G., Recent advances in diagnostic and therapeutic strategies (1999) Ann. Intern. Med., 30, pp. 764-771. , Bornstein SR, moderator, Adrenocortical tumors: Recent advances in basic concepts and clinical management
Latronico, A.C., Chrousos, G.P., Extensive personal experience: Adrenocortical tumors (1997) J. Clin. Endocrinol. Metab., 82, pp. 1317-1324
Stojadinovic, A., Ghossein, R.A., Hoos, A., Adrenocortical carcinoma: Clinical, morphologic, and molecular characterization (2002) J. Clin. Oncol., 20, pp. 941-950
Sasano, H., Suzuki, T., Moriya, T., Discerning malignancy in resected adrenocortical neoplasms (2001) Endocr. Pathol., 12, pp. 397-406
Hutter, A.M., Kayhoe, D.E., Adrenal cortical carcinoma: Clinical features in 138 patients (1966) Am. J. Med., 41, pp. 572-580
Sullivan, M., Boileau, M., Hodges, C.V., Adrenal cortical carcinoma (1978) J. Urol., 120, pp. 660-665
Weiss, L.M., Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors (1984) Am. J. Surg. Pathol., 8, pp. 163-169
Weiss, L.M., Medeiros, L.J., Vickety, A.L., Pathologic features of prognostic significance in adrenocortical carcinoma (1989) Am. J. Surg. Pathol., 13, pp. 202-206
Rossi, R., Tauchmanovà, L., Luciano, A., Subclinical Cushing's syndrome in patients with adrenal incidentaloma. Clinical and biochemical features (2000) J. Clin. Endocrinol. Metab., 85, pp. 1440-1448
Rosai, J., Adrenal gland and other paraganglia (1996) Ackerman's Surgical Pathology, 1. , Rosai R, editors, 8th edition, St. Louis, Mosby
Kasperlik-Zaluska, A., Migdalska, B.M., Zglicznski, S., Adrenocortical carcinoma. A clinical study and treatment result of 52 patients (1995) Cancer, 75, pp. 2587-2591
Wooten, M.D., King, D.K., Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature (1993) Cancer, 72, pp. 3145-3155
McKenna, T.J., Miller, R.B., Liddle, G.W., Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess or idiopathic hirsutism (1977) J. Clin. Endocrinol. Metab., 44, pp. 231-234
Medonca, B.B., Lucon, A.M., Menezes, C.A., Clinical, hormonal and pathological findings in a comparative study of adrenal cortical neoplasms in childhood and adulthood (1995) J. Urol., 154, pp. 2004-2009
Kaye, T.B., Crapo, L., The Cushing's syndrome: An update on diagnostic tests (1990) Ann. Intern. Med., 112, pp. 434-444
Reincke, M., Nieke, J., Krestin, G.P., Preclinical Cushing's syndrome in adrenal "incidentalomas": Comparison with adrenal Cushing's syndrome (1992) J. Clin. Endocrinol. Metab., 75, pp. 826-832
Ambrosi, B., Sartorio, A., Pizzocaro, A., Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma (2000) Exp. Clin. Endocrinol. Diabetes, 108, pp. 294-298
Barzon, L., Zucchetta, P., Boscaro, M., Scintigraphic pattern of adrenocortical carcinoma: Morpho-functional correlates (2001) Eur. J. Endocrinol., 145, pp. 743-748
Pommier, R.F., Brennan, M.F., An eleven-year experience with adrenocortical carcinoma (1992) Surgery, 112, pp. 963-970
Haak, H.R., Hermans, J., Van De Velde, C.J., Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients (1994) Br. J. Cancer, 69, pp. 947-951
Khoram-Manesh, A., Ahlman, H., Jansson, S., Adrenocortical carcinoma: Surgery and mitotane for treatment and steroid profiles for follow-up (1998) World J. Surg., 2, pp. 605-611
Terzolo, M., Anna-Pia, A., Berruti, A., Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer (2000) J. Clin. Endocrinol. Metab., 85, pp. 2234-2238
Schteingart, D.E., Treating adrenal cancer (1992) Endocrinologist, 2, pp. 149-157
Bates, S.E., Shieh, C.Y., Mickley, L.A., Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/p-glycoprotein) which is also expressed by adrenocortical carcinomas (1991) J. Clin. Endocrinol. Metab., 73, pp. 18-29
Ahlman, H., Khorram-Manesh, A., Jansson, S., Cytotoxic treatment of adrenocortical carcinoma (2001) World J. Surg., 25, pp. 927-933
Hogan, T.F., Gilchrist, K.W., Westring, D.W., A clinical and pathological study of adrenocortical carcinoma: Therapeutic implications (1980) Cancer, 45, pp. 2880-2883
Wachenfeld, C., Beuschlein, F., Zwermann, O., Discerning malignancy in adrenocortical tumors: Are molecular markers useful? (2001) Eur. J. Endocrinol., 145, pp. 335-341
Hanna, N. H., Kenady, E., Advances in the management of adrenal tumours (2000) Curr. Opin. Oncol., 11, pp. 49-5
Thompson, N. W., Cheung, P. S. Y., Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas (1987) Surg. Clin. North Am., 67, pp. 423-436
S reide, J. A., Brabrand, K., Thoresen, S., Adrenal cortical carcinoma in Norway, 1970-1984 (1992) World J. Surg., 16, pp. 663-668
McFarlane, D. A., Cancer of the adrenal cortex: The natural history, prognosis and treatment in a study of fifty-five cases (1958) Ann. R. Coll. Surg. Engl., 23, p. 155
Luton, J. P., Cerdas, S., Billaud, L., Clinical features of adrenocortical carinoma, prognostic factors, and the effects of mitotane therapy (1990) N. Engl. J. Med., 322, pp. 1195-1201
Henley, D. J., Van Heerden, J. A., Grant, C. S., Adrenal cortical carcinoma: A continuing challenge (1983) Surgery, 94, pp. 926-931
Decker, R. A., Kuehner, M. E., Adrenocortical carcinoma (1991) Am. Surg., 57, pp. 502-513
Wajchenberg, B. L., Albergaria-Pereira, M. A., Adrenocortical carcinoma: Clinical and laboratory observation (2000) Cancer, 88, pp. 711-736
Latronico, A. C., Chrousos, G. P., Extensive personal experience: Adrenocortical tumors (1997) J. Clin. Endocrinol. Metab., 82, pp. 1317-1324
Hutter, A. M., Kayhoe, D. E., Adrenal cortical carcinoma: Clinical features in 138 patients (1966) Am. J. Med., 41, pp. 572-580
Weiss, L. M., Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors (1984) Am. J. Surg. Pathol., 8, pp. 163-169
Weiss, L. M., Medeiros, L. J., Vickety, A. L., Pathologic features of prognostic significance in adrenocortical carcinoma (1989) Am. J. Surg. Pathol., 13, pp. 202-206
Wooten, M. D., King, D. K., Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature (1993) Cancer, 72, pp. 3145-3155
McKenna, T. J., Miller, R. B., Liddle, G. W., Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess or idiopathic hirsutism (1977) J. Clin. Endocrinol. Metab., 44, pp. 231-234
Medonca, B. B., Lucon, A. M., Menezes, C. A., Clinical, hormonal and pathological findings in a comparative study of adrenal cortical neoplasms in childhood and adulthood (1995) J. Urol., 154, pp. 2004-2009
Kaye, T. B., Crapo, L., The Cushing's syndrome: An update on diagnostic tests (1990) Ann. Intern. Med., 112, pp. 434-444
Pommier, R. F., Brennan, M. F., An eleven-year experience with adrenocortical carcinoma (1992) Surgery, 112, pp. 963-970
Haak, H. R., Hermans, J., Van De Velde, C. J., Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients (1994) Br. J. Cancer, 69, pp. 947-951
Schteingart, D. E., Treating adrenal cancer (1992) Endocrinologist, 2, pp. 149-157
Bates, S. E., Shieh, C. Y., Mickley, L. A., Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/p-glycoprotein) which is also expressed by adrenocortical carcinomas (1991) J. Clin. Endocrinol. Metab., 73, pp. 18-29
Hogan, T. F., Gilchrist, K. W., Westring, D. W., A clinical and pathological study of adrenocortical carcinoma: Therapeutic implications (1980) Cancer, 45, pp. 2880-2883
World J Surg (ISSN: 0364-2313), 2004 Sep; 28(9): 896-903.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 1.952, 5-year impact factor: 2.79
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-6344264964&partnerID=40&md5=9b1766d87c182402cc1baa1e393aa632
Keywords: Androstenedione, Estradiol, Estriol, Hydroxyprogesterone, Prasterone Sulfate, Testosterone, Adrenal Cortex Carcinoma, Adult, Arterial Pressure, Article, Cancer Recurrence, Cancer Staging, Cancer Surgery, Cardiovascular Risk, Clinical Article, Clinical Feature, Disease Association, Disease Severity, Early Diagnosis, Endocrine Function, Female, Human, Hyperadrenocorticism, Hypertension, Metabolic Regulation, Patient Monitoring, Prediction, Prognosis, Prospective Study, Rare Disease, Risk Factor, Adrenal Cortex Neoplasms, Adrenocortical Carcinoma, Middle Aged, Prospective Studies, Time Factors, Treatment Outcome,
Affiliations:
*** IBB - CNR ***
Dept. of Molec./Clin. Endocrinol., Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
Dept. of Anat. Pathol. and Cytology, Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
Dept. of Biomorphol. and Funct. Sci., Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
Dept. of Molec. /Clin. Endocrinol., Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy
References:
Hanna, N.H., Kenady, E., Advances in the management of adrenal tumours (2000) Curr. Opin. Oncol., 11, pp. 49-5
Thompson, N.W., Cheung, P.S.Y., Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas (1987) Surg. Clin. North Am., 67, pp. 423-436
Søreide, J.A., Brabrand, K., Thoresen, Sø., Adrenal cortical carcinoma in Norway, 1970-1984 (1992) World J. Surg., 16, pp. 663-668
McFarlane, D.A., Cancer of the adrenal cortex: The natural history, prognosis and treatment in a study of fifty-five cases (1958) Ann. R. Coll. Surg. Engl., 23, p. 155
Luton, J.P., Cerdas, S., Billaud, L., Clinical features of adrenocortical carinoma, prognostic factors, and the effects of mitotane therapy (1990) N. Engl. J. Med., 322, pp. 1195-1201
Henley, D.J., Van Heerden, J.A., Grant, C.S., Adrenal cortical carcinoma: A continuing challenge (1983) Surgery, 94, pp. 926-931
Decker, R.A., Kuehner, M.E., Adrenocortical carcinoma (1991) Am. Surg., 57, pp. 502-513
Icard, P., Goudet, P., Charpenay, C., Adrenocortical carcinomas: Surgical trends and results of a 253 patient series from the French Association of Endocrine Surgeons study group (2001) World J. Surg., 25, pp. 891-897
Vassilopoulou-Sellin, R., Schultz, P.N., Adrenocortical carcinoma. Clinical outcome at the end of the 20th century (2001) Cancer, 92, pp. 1113-1121
Mantero, F., Terzolo, M., Arnaldi, G., Survey on adrenal incidentaloma in Italy (2000) J. Clin. Endocrinol. Metab., 85, pp. 637-644
Zarrilli, L., Marzano, L.A., Tauchmanovà, L., Incidentalomi surrenalici: Risultato di uno studio prospettico di 100 casi. Focus - La chirurgia dei surreni oggi. Ospedali d'Italia (1999) Chirurgia (Bucur), 5, pp. 655-659
Wajchenberg, B.L., Albergaria-Pereira, M.A., Adrenocortical carcinoma: Clinical and laboratory observation (2000) Cancer, 88, pp. 711-736
Bertagna, Ch., Orth, D.N., Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Review (1981) Am. J. Med., 71, pp. 855-875
Chrousos, G., Recent advances in diagnostic and therapeutic strategies (1999) Ann. Intern. Med., 30, pp. 764-771. , Bornstein SR, moderator, Adrenocortical tumors: Recent advances in basic concepts and clinical management
Latronico, A.C., Chrousos, G.P., Extensive personal experience: Adrenocortical tumors (1997) J. Clin. Endocrinol. Metab., 82, pp. 1317-1324
Stojadinovic, A., Ghossein, R.A., Hoos, A., Adrenocortical carcinoma: Clinical, morphologic, and molecular characterization (2002) J. Clin. Oncol., 20, pp. 941-950
Sasano, H., Suzuki, T., Moriya, T., Discerning malignancy in resected adrenocortical neoplasms (2001) Endocr. Pathol., 12, pp. 397-406
Hutter, A.M., Kayhoe, D.E., Adrenal cortical carcinoma: Clinical features in 138 patients (1966) Am. J. Med., 41, pp. 572-580
Sullivan, M., Boileau, M., Hodges, C.V., Adrenal cortical carcinoma (1978) J. Urol., 120, pp. 660-665
Weiss, L.M., Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors (1984) Am. J. Surg. Pathol., 8, pp. 163-169
Weiss, L.M., Medeiros, L.J., Vickety, A.L., Pathologic features of prognostic significance in adrenocortical carcinoma (1989) Am. J. Surg. Pathol., 13, pp. 202-206
Rossi, R., Tauchmanovà, L., Luciano, A., Subclinical Cushing's syndrome in patients with adrenal incidentaloma. Clinical and biochemical features (2000) J. Clin. Endocrinol. Metab., 85, pp. 1440-1448
Rosai, J., Adrenal gland and other paraganglia (1996) Ackerman's Surgical Pathology, 1. , Rosai R, editors, 8th edition, St. Louis, Mosby
Kasperlik-Zaluska, A., Migdalska, B.M., Zglicznski, S., Adrenocortical carcinoma. A clinical study and treatment result of 52 patients (1995) Cancer, 75, pp. 2587-2591
Wooten, M.D., King, D.K., Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature (1993) Cancer, 72, pp. 3145-3155
McKenna, T.J., Miller, R.B., Liddle, G.W., Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess or idiopathic hirsutism (1977) J. Clin. Endocrinol. Metab., 44, pp. 231-234
Medonca, B.B., Lucon, A.M., Menezes, C.A., Clinical, hormonal and pathological findings in a comparative study of adrenal cortical neoplasms in childhood and adulthood (1995) J. Urol., 154, pp. 2004-2009
Kaye, T.B., Crapo, L., The Cushing's syndrome: An update on diagnostic tests (1990) Ann. Intern. Med., 112, pp. 434-444
Reincke, M., Nieke, J., Krestin, G.P., Preclinical Cushing's syndrome in adrenal "incidentalomas": Comparison with adrenal Cushing's syndrome (1992) J. Clin. Endocrinol. Metab., 75, pp. 826-832
Ambrosi, B., Sartorio, A., Pizzocaro, A., Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma (2000) Exp. Clin. Endocrinol. Diabetes, 108, pp. 294-298
Barzon, L., Zucchetta, P., Boscaro, M., Scintigraphic pattern of adrenocortical carcinoma: Morpho-functional correlates (2001) Eur. J. Endocrinol., 145, pp. 743-748
Pommier, R.F., Brennan, M.F., An eleven-year experience with adrenocortical carcinoma (1992) Surgery, 112, pp. 963-970
Haak, H.R., Hermans, J., Van De Velde, C.J., Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients (1994) Br. J. Cancer, 69, pp. 947-951
Khoram-Manesh, A., Ahlman, H., Jansson, S., Adrenocortical carcinoma: Surgery and mitotane for treatment and steroid profiles for follow-up (1998) World J. Surg., 2, pp. 605-611
Terzolo, M., Anna-Pia, A., Berruti, A., Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer (2000) J. Clin. Endocrinol. Metab., 85, pp. 2234-2238
Schteingart, D.E., Treating adrenal cancer (1992) Endocrinologist, 2, pp. 149-157
Bates, S.E., Shieh, C.Y., Mickley, L.A., Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/p-glycoprotein) which is also expressed by adrenocortical carcinomas (1991) J. Clin. Endocrinol. Metab., 73, pp. 18-29
Ahlman, H., Khorram-Manesh, A., Jansson, S., Cytotoxic treatment of adrenocortical carcinoma (2001) World J. Surg., 25, pp. 927-933
Hogan, T.F., Gilchrist, K.W., Westring, D.W., A clinical and pathological study of adrenocortical carcinoma: Therapeutic implications (1980) Cancer, 45, pp. 2880-2883
Wachenfeld, C., Beuschlein, F., Zwermann, O., Discerning malignancy in adrenocortical tumors: Are molecular markers useful? (2001) Eur. J. Endocrinol., 145, pp. 335-341
Hanna, N. H., Kenady, E., Advances in the management of adrenal tumours (2000) Curr. Opin. Oncol., 11, pp. 49-5
Thompson, N. W., Cheung, P. S. Y., Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas (1987) Surg. Clin. North Am., 67, pp. 423-436
S reide, J. A., Brabrand, K., Thoresen, S., Adrenal cortical carcinoma in Norway, 1970-1984 (1992) World J. Surg., 16, pp. 663-668
McFarlane, D. A., Cancer of the adrenal cortex: The natural history, prognosis and treatment in a study of fifty-five cases (1958) Ann. R. Coll. Surg. Engl., 23, p. 155
Luton, J. P., Cerdas, S., Billaud, L., Clinical features of adrenocortical carinoma, prognostic factors, and the effects of mitotane therapy (1990) N. Engl. J. Med., 322, pp. 1195-1201
Henley, D. J., Van Heerden, J. A., Grant, C. S., Adrenal cortical carcinoma: A continuing challenge (1983) Surgery, 94, pp. 926-931
Decker, R. A., Kuehner, M. E., Adrenocortical carcinoma (1991) Am. Surg., 57, pp. 502-513
Wajchenberg, B. L., Albergaria-Pereira, M. A., Adrenocortical carcinoma: Clinical and laboratory observation (2000) Cancer, 88, pp. 711-736
Latronico, A. C., Chrousos, G. P., Extensive personal experience: Adrenocortical tumors (1997) J. Clin. Endocrinol. Metab., 82, pp. 1317-1324
Hutter, A. M., Kayhoe, D. E., Adrenal cortical carcinoma: Clinical features in 138 patients (1966) Am. J. Med., 41, pp. 572-580
Weiss, L. M., Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors (1984) Am. J. Surg. Pathol., 8, pp. 163-169
Weiss, L. M., Medeiros, L. J., Vickety, A. L., Pathologic features of prognostic significance in adrenocortical carcinoma (1989) Am. J. Surg. Pathol., 13, pp. 202-206
Wooten, M. D., King, D. K., Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature (1993) Cancer, 72, pp. 3145-3155
McKenna, T. J., Miller, R. B., Liddle, G. W., Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess or idiopathic hirsutism (1977) J. Clin. Endocrinol. Metab., 44, pp. 231-234
Medonca, B. B., Lucon, A. M., Menezes, C. A., Clinical, hormonal and pathological findings in a comparative study of adrenal cortical neoplasms in childhood and adulthood (1995) J. Urol., 154, pp. 2004-2009
Kaye, T. B., Crapo, L., The Cushing's syndrome: An update on diagnostic tests (1990) Ann. Intern. Med., 112, pp. 434-444
Pommier, R. F., Brennan, M. F., An eleven-year experience with adrenocortical carcinoma (1992) Surgery, 112, pp. 963-970
Haak, H. R., Hermans, J., Van De Velde, C. J., Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients (1994) Br. J. Cancer, 69, pp. 947-951
Schteingart, D. E., Treating adrenal cancer (1992) Endocrinologist, 2, pp. 149-157
Bates, S. E., Shieh, C. Y., Mickley, L. A., Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/p-glycoprotein) which is also expressed by adrenocortical carcinomas (1991) J. Clin. Endocrinol. Metab., 73, pp. 18-29
Hogan, T. F., Gilchrist, K. W., Westring, D. W., A clinical and pathological study of adrenocortical carcinoma: Therapeutic implications (1980) Cancer, 45, pp. 2880-2883
Andrenocortical carcinomas: Twelve-year prospective experience
Adrenocortical carcinoma (AC) is a rare tumor with poor prognosis. Twenty-two patients (14 F, 8 M; age 22 to 59 years; median, 43 years) with AC were evaluated prospectively in a single center: tumor stage was I-II in 12 cases and III-IV in 10. The overall survival in our cohort was 41.6 ± 42 months; 16 subjects are still alive. Curative surgery was followed by longer survival than debulking or no surgery (p < 0.0001). The first relapse was highly predictive for further recurrences. Recurrent ACs were progressively more aggressive, and they occurred with variable but ever shorter intervals. At diagnosis, 14 patients (63.5%) presented with features of clear adrenocortical hyperactivity. Despite the absence of clinical signs of hormonal excess, all other patients presented some abnormalities of steroid secretion. The most common clinical findingwas a recent diagnosis of moderate-to-severe hypertension (68%), poorly controlled by pharmacological treatment, often associated with multiple cardiovascular risk factors. High mitotic rate and undifferentiated polymorph cellular pattern were associated with worse prognosis. Response to treatments other than surgery (mitotane chemotherapy) was better in patients treated early after the first surgery. In conclusion, curative surgery was the most effective treatment. Monitoring arterial pressure, endocrine parameters, and metabolic parameters can be helpful for the early detection of AC recurrences.
Adrenocortical carcinoma (AC) is a rare tumor with poor prognosis. Twenty-two patients (14 F, 8 M; age 22 to 59 years; median, 43 years) with AC were evaluated prospectively in a single center: tumor stage was I-II in 12 cases and III-IV in 10. The overall survival in our cohort was 41.6 ± 42 months; 16 subjects are still alive. Curative surgery was followed by longer survival than debulking or no surgery (p < 0.0001). The first relapse was highly predictive for further recurrences. Recurrent ACs were progressively more aggressive, and they occurred with variable but ever shorter intervals. At diagnosis, 14 patients (63.5%) presented with features of clear adrenocortical hyperactivity. Despite the absence of clinical signs of hormonal excess, all other patients presented some abnormalities of steroid secretion. The most common clinical findingwas a recent diagnosis of moderate-to-severe hypertension (68%), poorly controlled by pharmacological treatment, often associated with multiple cardiovascular risk factors. High mitotic rate and undifferentiated polymorph cellular pattern were associated with worse prognosis. Response to treatments other than surgery (mitotane chemotherapy) was better in patients treated early after the first surgery. In conclusion, curative surgery was the most effective treatment. Monitoring arterial pressure, endocrine parameters, and metabolic parameters can be helpful for the early detection of AC recurrences.
Andrenocortical carcinomas: Twelve-year prospective experience
No results. |
Andrenocortical carcinomas: Twelve-year prospective experience
Other filter: ([btitle,keywords] "Androstenedione" OR ...
Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (1653 views)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
View Export to BibTeX Export to EndNote
Maurea S, Soricelli A, Salvatore M
* Characterization of hypersecreting or non-hypersecreting adrenal adenomas: Comparison between iodine-131 nor-cholesterol scintigraphy and magnetic resonance imaging (315 views) (PDF 247 views)
Curr Radiopharm (ISSN: 1874-4710, 1874-4729), 2009; 2(1): 56-62.
Impact Factor: 0.643
View Export to BibTeX Export to EndNote
Tauchmanova L, Pivonello R, De Martino MC, Rusciano A, De Leo M, Ruosi C, Mainolfi C, Lombardi G, Salvatore M, Colao A
* Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism (368 views)
Eur J Endocrinol (ISSN: 0804-4643), 2007 Sep; 157(3): 359-366.
Impact Factor: 3.239
View Export to BibTeX Export to EndNote
Maurea S, Imbriaco M, D'Angelillo M, Mollica C, Camera L, Salvatore M
* Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions (327 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2006 Sep; 111(5): 674-686.
Impact Factor: 1.368
View Export to BibTeX Export to EndNote
Tauchmanovà L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L, Klain M, Salvatore M, Lombardi G, Colao A
* Bone demineralization and vertebral fractures in endogenous cortisol excess: Role of disease etiology and gonadal status (326 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2006 May; 91(5): 1779-1784.
Impact Factor: 5.799
View Export to BibTeX Export to EndNote
Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G
* Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency (422 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2005 Sep; 90(9): 5146-5155.
Impact Factor: 6.02
View Export to BibTeX Export to EndNote
Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M
* Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques (348 views) (PDF 247 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2004; 48(3): 188-197.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Maurea S, Mainolfi C, Bazzicalupo L, Panico MR, Imparato C, Alfano B, Ziviello M, Salvatore M
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions (355 views) (PDF 247 views)
Ajr Am J Roentgenol (ISSN: 0361-803x, 0361-803xlinking), 1999 Jul; 173(1): 25-29.
Impact Factor: 2.307
View Export to BibTeX Export to EndNote
Maurea S, Mainolfi C, Bazzicalupo L, Panico M, Imparato C, Alfano B, Ziviello M, Salvatore M
Characterization of adrenal tumors using F-18 FDG PET imaging: Comparison between benign and malignant lesions (440 views) (PDF 247 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 May; 38(5SUPPL.): 25-29.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID
Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells (442 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1990 Dec 15; 50(24): 7858-7862.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (1653 views)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
View Export to BibTeX Export to EndNote
Maurea S, Soricelli A, Salvatore M
* Characterization of hypersecreting or non-hypersecreting adrenal adenomas: Comparison between iodine-131 nor-cholesterol scintigraphy and magnetic resonance imaging (315 views) (PDF 247 views)
Curr Radiopharm (ISSN: 1874-4710, 1874-4729), 2009; 2(1): 56-62.
Impact Factor: 0.643
View Export to BibTeX Export to EndNote
Tauchmanova L, Pivonello R, De Martino MC, Rusciano A, De Leo M, Ruosi C, Mainolfi C, Lombardi G, Salvatore M, Colao A
* Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism (368 views)
Eur J Endocrinol (ISSN: 0804-4643), 2007 Sep; 157(3): 359-366.
Impact Factor: 3.239
View Export to BibTeX Export to EndNote
Maurea S, Imbriaco M, D'Angelillo M, Mollica C, Camera L, Salvatore M
* Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions (327 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2006 Sep; 111(5): 674-686.
Impact Factor: 1.368
View Export to BibTeX Export to EndNote
Tauchmanovà L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L, Klain M, Salvatore M, Lombardi G, Colao A
* Bone demineralization and vertebral fractures in endogenous cortisol excess: Role of disease etiology and gonadal status (326 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2006 May; 91(5): 1779-1784.
Impact Factor: 5.799
View Export to BibTeX Export to EndNote
Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G
* Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency (422 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2005 Sep; 90(9): 5146-5155.
Impact Factor: 6.02
View Export to BibTeX Export to EndNote
Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M
* Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques (348 views) (PDF 247 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2004; 48(3): 188-197.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Maurea S, Mainolfi C, Bazzicalupo L, Panico MR, Imparato C, Alfano B, Ziviello M, Salvatore M
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions (355 views) (PDF 247 views)
Ajr Am J Roentgenol (ISSN: 0361-803x, 0361-803xlinking), 1999 Jul; 173(1): 25-29.
Impact Factor: 2.307
View Export to BibTeX Export to EndNote
Maurea S, Mainolfi C, Bazzicalupo L, Panico M, Imparato C, Alfano B, Ziviello M, Salvatore M
Characterization of adrenal tumors using F-18 FDG PET imaging: Comparison between benign and malignant lesions (440 views) (PDF 247 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 May; 38(5SUPPL.): 25-29.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID
Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells (442 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1990 Dec 15; 50(24): 7858-7862.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
10 Records (10 excluding Abstracts).
Total impact factor: 52.375 (52.375 excluding Abstracts).
Total 5 year impact factor: 50.385 (50.385 excluding Abstracts).
Total impact factor: 52.375 (52.375 excluding Abstracts).
Total 5 year impact factor: 50.385 (50.385 excluding Abstracts).
294 views. Last view on Sunday 26 March 2023, 18:21:57
ibb.cnr.it
